Status:
UNKNOWN
Osteoporosis and Dental Implant
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Osteoporosis
Eligibility:
FEMALE
60-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the influence of alendronate therapy on the wound healing after dental implants in patients with osteoporosis.
Eligibility Criteria
Inclusion
- Postmenopausal women \> 2 years after menopause
- Age between 60 and 75 years
- Possibility to insert a dental implant
- Osteoporosis as defined by WHO criteria (intervention group), or women without osteoporosis / osteopenia (non-intervention group)
Exclusion
- Pathological findings in the jaw bone
- Chronic inflammatory rheumatoid disease
- Bisphosphonate treatments during the last 12 months
- Inflammatory or metabolic bone disease, excluding osteoporosis
- Systemic corticosteroid treatments of more than one month within previous 12 months
- Severe diseases with life expectancy less than one year or expectation of rapid worsening within one year
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00727493
Start Date
January 1 2004
End Date
April 1 2010
Last Update
August 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Muscle and Bone Research, Charité - Campus Benjamin Franklin
Berlin, Germany, 12200